Pharmaceutical interactions between antiretroviral and antimalarial drugs used in chemoprophylaxis

作者: Andreas Erich Zautner , Ottmar Herchenröder , Awatef El Moussi , Norbert Georg Schwarz , Dorothea Franziska Wiemer

DOI: 10.1016/J.ACTATROPICA.2017.12.021

关键词:

摘要: Human immunodeficiency virus (HIV) is the causative agent of Acquired Immunodeficiency Syndrome (AIDS). The pandemic believed to have originated within Northern Congo basin covering large parts Democratic Republic Congo, Central African Republic, Cameroon and Gabon. Although over decades, HIV-1 has spread throughout World leaving no country unaffected, sub-Saharan Africa remains region with more than 80% all infected individuals. HIV-2 epidemic largely remained restricted West along Upper Guinean forests. Co-incident these regions highest HIV distribution a part malaria belt therefore, co-infections are common. In this review we carve out consequences transmission prevention synchronous prophylaxis during occupational or leisure travelling activities region. particular, elaborate on considering pre-existing drug resistances both, parasites viruses, when determining combination for prophylactic and, if necessary, post-expositional measures focus compatibility both medications.

参考文章(84)
Jérôme Chevillotte, Recommandations sanitaires pour les voyageurs Elsevier Masson. ,(2009)
Sheena McCormack, David T Dunn, Monica Desai, David I Dolling, Mitzy Gafos, Richard Gilson, Ann K Sullivan, Amanda Clarke, Iain Reeves, Gabriel Schembri, Nicola Mackie, Christine Bowman, Charles J Lacey, Vanessa Apea, Michael Brady, Julie Fox, Stephen Taylor, Simone Antonucci, Saye H Khoo, James Rooney, Anthony Nardone, Martin Fisher, Alan McOwan, Andrew N Phillips, Anne M Johnson, Brian Gazzard, Owen N Gill, Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial The Lancet. ,vol. 387, pp. 53- 60 ,(2016) , 10.1016/S0140-6736(15)00056-2
Richard M. Hoglund, Pauline Byakika‐Kibwika, Mohammed Lamorde, Concepta Merry, Michael Ashton, Warunee Hanpithakpong, Nicholas P. J. Day, Nicholas J. White, Angela Äbelö, Joel Tarning, Artemether-lumefantrine co-administration with antiretrovirals: population pharmacokinetics and dosing implications British Journal of Clinical Pharmacology. ,vol. 79, pp. 636- 649 ,(2015) , 10.1111/BCP.12529
K K Srivastava, R Fernandez-Larsson, D M Zinkus, H L Robinson, Human immunodeficiency virus type 1 NL4-3 replication in four T-cell lines: rate and efficiency of entry, a major determinant of permissiveness. Journal of Virology. ,vol. 65, pp. 3900- 3902 ,(1991) , 10.1128/JVI.65.7.3900-3902.1991
Susan C Weller, Karen Davis-Beaty, Condom effectiveness in reducing heterosexual HIV transmission Cochrane Database of Systematic Reviews. ,(2002) , 10.1002/14651858.CD003255
Siwalee Rattanapunya, Tim R. Cressey, Ronnatrai Rueangweerayut, Yardpiroon Tawon, Panida Kongjam, Kesara Na-Bangchang, Pharmacokinetic interactions between artesunate-mefloquine and ritonavir-boosted lopinavir in healthy Thai adults. Malaria Journal. ,vol. 14, pp. 400- 400 ,(2015) , 10.1186/S12936-015-0916-8
Josef Eberle, Jürgen Habermann, Lutz G. Gürtler, HIV-1 infection transmitted by serum droplets into the eye: a case report. AIDS. ,vol. 14, pp. 206- 207 ,(2000) , 10.1097/00002030-200001280-00019
Hagen Frickmann, B Wulff, U Loderstædt, R M Hagen, D Sturm, S Polywka, From IEDs to AIDS? Detection of HIV in human corpses by rapid screening tests after suspected intentional transmission in terrorist attacks Journal of the Royal Army Medical Corps. ,vol. 159, pp. 278- 282 ,(2013) , 10.1136/JRAMC-2013-000048
S. Abgrall, J. Le Bel, N. Lele, C. Laouénan, N. Eychenne, F. Mentré, G. Peytavin, O. Bouchaud, , Lack of Effect of Doxycycline on Trough Concentrations of Protease Inhibitors or Non-Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Hiv Clinical Trials. ,vol. 14, pp. 313- 318 ,(2013) , 10.1310/HCT1406-313